. Author manuscript; available in PMC: 2014 Oct 29.

Published in final edited form as: Inhal Toxicol. 2014 Aug;26(10):588–597. doi: 10.3109/08958378.2014.937882

Table 2.

Summary of FACS Analysis

Cell Analyzed	Direction of Change Compared to Control	p Value
Bone Marrow EPCs
SCA-1+/VEGF-R2+/CD45−	Increase in number	0.006
SCA-1+/VEGF-R2+/CD45+	Increase in number	0.009
SCA-1+/VEGF-R2+	Increase in number	0.006
Circulating EPCs
SCA-1+/VEGF-R2+/CD45−	Increase in number	0.038
SCA-1+/VEGF-R2+/CD45+	Increase in number	0.00005
SCA-1+/VEGF-R2+	Increase in number	0.00009
Circulating Endothelial Cells
CD31+/CD146+	Increase in number	0.0004
Endothelial Microparticles
CD31+/CD146+	--	0.758

-- denotes no significant directional change